Acute effects of olanzapine on behavioural expression including the behavioural satiety sequence in female rats

Journal of Psychopharmacology

Volumn 24, Issue 7, 2010, Pages 1069-1078

  Cooper, G D ^a   Goudie, A J ^a   Halford, J C G ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Antipsychotic; Behavioural satiety sequence; Hyperphagia; Olanzapine; Rat; Weight gain

Indexed keywords

OLANZAPINE;

ANIMAL BEHAVIOR; ARTICLE; DRUG DOSE COMPARISON; DRUG EFFECT; FEEDING BEHAVIOR; FEMALE; HYPERPHAGIA; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SATIETY;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BENZODIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY INTAKE; EXPLORATORY BEHAVIOR; FEEDING BEHAVIOR; FEMALE; HYPERPHAGIA; RATS; RATS, WISTAR; SATIETY RESPONSE; WEIGHT GAIN;

EID: 77953801663     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109102543     Document Type: Article

References (54)

1. Albaugh, VL, Henry, CR, Bello, NT, Hajnal, A., Lynch, SL, Halle, B., et al. (2006) Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents. Obes Res 14: 36-51.
2. Allison, DB, Mentore, JL, Heo, M., Chandler, LP, Cappelleri, JC, Infante, MC, et al. (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156: 1686-1696.
3. Antin, J., Gibbs, J., Holt, J., Young, RC, Smith, GP (1975) Cholecystokinin elicits the complete behavioral sequence of satiety in rats. J Comp Physiol Psychol 89: 784-790.
4. Aravagiri, M., Teper, Y., Marder, SR (1999) Pharmacokinetics and tissue distribution of olanzapine in rats. Biopharm Drug Dispos 20: 369-377.
5. Arjona, AA, Zhang, SX, Adamson, B., Wurtman, RJ (2004) An animal model of antipsychotic-induced weight gain. Behav Brain Res 152: 121-127.
6. Baptista, T., de Baptista, EA, Kin, N., Beaulieu, S., Walker, D., Joober, R., et al. (2002) Comparative effects of the antipsychotics sulpiride or risperidone in rats - bodyweight, food intake, body composition, hormones and glucose tolerance. Brain Res 957: 144-151.
7. Baptista, T., de Baptista, EA, Lalonde, J., Plamondon, J., Kin, NM, Beaulieu, S., et al. (2004) Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection. Prog Neuropsychopharmacol 28: 1305-1311.
8. Benvenga, MJ, Leander, JD (1997) Increased food consumption by clozapine, but not by olanzapine, in satiated rats. Drug Dev Res 41: 48-50.
9. Campbell, M., Young, PI, Bateman, DN, Smith, JM, Thomas, SH (1999) The use of atypical antipsychotics in the management of schizophrenia. Br J Clin Pharmacol 47: 13-22.
10. Choi, S., DiSlivio, B., Unangst, J., Fernstrom, JD (2007) Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats. Life Sci 81: 1024-1030.
11. Clifton, PG, Cooper, SJ (1996) The benzodiazepine partial receptor agonist, bretazenil, provokes a strong hyperphagic response: a meal pattern analysis in free feeding rats. Behav Pharmacol 7: 454-461.
12. Conley, RR, Kelley, DL (2002) Current status of antipsychotic treatment. Curr Drug Targets CNS Neurol Disord 1: 123-128.
13. Cooper, GD, Harrold, JA, Halford, JCG, Goudie, AJ (2008) Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic induced weight gain. Prog Neuropsychopharmacol Biol Psychiatry 32: 428-436.
14. Cooper, GD, Pickavance, LC, Harrold, JA, Wilding, JPH, Halford, JCG, Goudie, AJ (2007) Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities. J Psychopharmacol 21: 405-413.
15. Cooper, GD, Pickavance, LC, Wilding, JPH, Halford, JCG, Goudie, AJ (2005) A parametric analysis of olanzapine-induced weight gain in female rats. Psychopharmacology (Berl) 181: 80-89.
16. Ebenbichler, CF, Laimer, M., Eder, U., Mangweth, B., Weiss, E., Hofer, A., et al. (2003) Olanzapine induces insulin resistance: results from a prospective study. J Clin Psychiatry 64: 1436-1439.
17. Eder, U., Mangweth, B., Weiss, E., Hofer, A., Hummer, M., Kemmler, G., et al. (2001) Association of olanzapine-induced weight gain with an increase in body fat. Am J Psychiatry 158: 1719-1722.
18. Goodson, S., Halford, JCG, Blundell, JE (2004) Direct, continuous behavioral analysis of drug action on feeding. Curr Protoc Neurosci Nov; Chapter 8:Unit 8.6C.
19. Gothelf, D., Falk, B., Singer, P., Kairi, M., Phillip, M., Zigel, L., et al. (2002) Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. Am J Psychiatry 159: 1055-1057.
20. Goudie, AJ, Taylor, A. (1998) Comparative characterisation of the discriminative stimulus properties of clozapine and other antipsychotics in rats. Psychopharmacology (Berl) 135: 392-400.
21. Graham, KA, Perkins, DO, Edwards, LJ, Barrier, RC, Lieberman, JA, Harp, JB (2005) Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis. Am J Psychiatry 162: 118-123.
22. Halford, JCG, Wanninayake, SC, Blundell, JE (1998) Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake. Pharmacol Biochem Behav 61: 159-168.
23. Hartfield, AW, Moore, NA, Clifton, PG (2003) Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat. Psychopharmacology 167: 115-122.
24. Hartfield, AW, Moore, NA, Clifton, PG (2006) Effects of atypical antipsychotic drugs on intralipid intake and cocaine-induced hyperactivity in rats. Neuropsychopharmacology 31: 1938-1945.
25. Hewitt, KN, Lee, MD, Dourish, CT, Clifton, PG (2002) Serotonin 2C receptor agonists and the behavioural satiety sequence in mice. Pharmacol Biochem Behav 71: 691-700.
26. Ishii, Y., Blundell, JE, Halford, JC, Rodgers, RJ (2003) Palatability, food intake and the behavioural satiety sequence in male rats. Physiol Behav 80: 37-47.
27. Ishii, Y., Blundell, JE, Halford, JC, Upton, N., Porter, R., Johns, A., et al. (2004) Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats. Physiol Behav 81: 129-140.
28. Ishii, Y., Blundell, JE, Halford, JC, Upton, N., Porter, R., Johns, A., et al. (2005 a) Satiety enhancement by selective orexin-1 receptor antagonist SB-334867: influence of test context and profile comparison with CCK-8S. Behav Brain Res 160: 11-24.
29. Ishii, Y., Blundell, JE, Halford, JC, Upton, N., Porter, R., Johns, A., et al. (2005 b) Anorexia and weight loss in male rats 24 h following single dose treatment with orexin-1 receptor antagonist SB-334867. Behav Brain Res 157: 331-341.
30. Jin, H., Meyer, JM, Jeste, DV (2004) Atypical antipsychotics and glucose dysregulation: a systematic review. Schizophr Res 71: 195-212.
31. Kalinichev, M., Rourke, C., Daniels, AJ, Grizzle, MK, Britt, CS, Ignar, DM, et al. (2005) Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats. Psychopharmacology (Berl) 182: 1-12.
32. Kane, JM (2007) Treatment adherence and long-term outcomes. CNS Spectr 10 (Suppl. 17). 21-26.
33. Kaur, G., Kulkarni, SK (2002) Studies on modulation of feeding behavior by atypical antipsychotics in female mice. Prog Neuropsychopharmacol 26: 277-285.
34. Kirkham, TC, Blundell, JE (1984) Dual action of naloxone on feeding revealed by behavioural analysis: separate effects on initiation and termination of eating. Appetite 5: 45-52.
35. Koro, CE, Meyer, JM (2005) Atypical antipsychotic therapy and hyperlipidemia: a review. Essent Psychopharmacol 6: 148-157.
36. Lee, MD, Clifton, PG (2002) Meal patterns of free feeding rats treated with clozapine, olanzapine, or haloperidol. Pharmacol Biochem Behav 71: 147-154.
37. Lee, MD, Summerville, EM, Kennett, GA, Dourish, CT, Clifton, PG (2004) Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice. Psychopharmacology (Berl) 176: 39-49.
38. McIntyre, RS, McCann, SM, Kennedy, SH (2001) Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Can J Psychiatry 46: 273-281.
39. Meyer, JM, Koro, CE (2004) The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophr Res 70: 1-17.
40. Nasrallah, HW (2003) A review of the effect of atypical antipsychotics on weight. Psychoneuroendocrinology 28: 83-96.
41. Nasrallah, HW (2006) Metabolic findings from the CATIE trial and their relation to tolerability. CNS Spectr 11 (Suppl. 7). 32-39.
42. Newcomer, JW (2005) Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 19 (Suppl. 1). 1-93.
43. Newcomer, JW (2007 a) Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry 68 (Suppl. 4). 8-13.
44. Newcomer, JW (2007 b) Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. J Clin Psychiatry 68 (Suppl. 1). 20-27.
45. Rodgers, RJ, Halford, JCG, Nunes de Souza, RL, Canto de Souza, AL, Piper, DC, Arch, JR, et al. (2000) Dose-response effects of orexin-A on food intake and the behavioural satiety sequence in rats. Regul Pept 96: 71-84.
46. Rodgers, RJ, Halford, JCG, Nunes de Souza, RL, Canto de Souza, AL, Piper, DC, Arch, JR, et al. (2001) SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur J Neurosci 13: 1444-1452.
47. Roerig, JL, Mitchell, JE, de Zwaan, M., Crosby, RD, Gosnell, BA, Steffen, KJ, et al. (2005) A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors. J Clin Psychopharmacol 25: 413-418.
48. Saddichha, S., Ameen, S., Akhtar, S. (2008) Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol. J Clin Psychopharmacol 28: 27-31.
49. Tallett, A., Blundell, JE, Rodgers, RJ (2008 a) Behaviourally-selective hypophagic effects of naloxone in non-deprived male rats presented with palatable food. Behav Brain Res 187: 417-427.
50. Tallett, A., Blundell, JE, Rodgers, RJ (2008 b) Endogenous opioids and cannabinoids: system interactions in the regulation of appetite, grooming and scratching. Physiol Behav 94: 422-431.
51. Tandon, R., Fleischhacker, WW (2005) Comparative efficacy of antipsychotics in the treatment of schizophrenia: a critical assessment. Schizophr Res 79: 145-155.
52. Thornton-Jones, Z., Neill, JC, Reynolds, GP (2002) The atypical antipsychotic olanzapine enhances ingestive behaviour in the rat: a preliminary study. J Psychopharmacol 16: 35-37.
53. Vestri, HS, Maianu, L., Moellering, DR, Garvey, WT (2007) Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis. Neuropsychopharmacology 32: 765-772.
54. Weiss, SM (1995) Pharmacological and behavioural examination of Laboratory mice to the calls of the Tawny Owl. PhD Thesis. University of Leeds.